AU4686299A - Nek-related and bub1-related protein kinases - Google Patents
Nek-related and bub1-related protein kinasesInfo
- Publication number
- AU4686299A AU4686299A AU46862/99A AU4686299A AU4686299A AU 4686299 A AU4686299 A AU 4686299A AU 46862/99 A AU46862/99 A AU 46862/99A AU 4686299 A AU4686299 A AU 4686299A AU 4686299 A AU4686299 A AU 4686299A
- Authority
- AU
- Australia
- Prior art keywords
- bub1
- nek
- protein kinases
- related protein
- kinases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8952098P | 1998-06-16 | 1998-06-16 | |
US60089520 | 1998-06-16 | ||
US9826598P | 1998-08-28 | 1998-08-28 | |
US60098265 | 1998-08-28 | ||
PCT/US1999/013533 WO1999066051A2 (fr) | 1998-06-16 | 1999-06-15 | Kinases en rapport avec nek et avec bub1 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4686299A true AU4686299A (en) | 2000-01-05 |
Family
ID=26780662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46862/99A Abandoned AU4686299A (en) | 1998-06-16 | 1999-06-15 | Nek-related and bub1-related protein kinases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1088079A2 (fr) |
JP (1) | JP2002518016A (fr) |
AU (1) | AU4686299A (fr) |
CA (1) | CA2331889A1 (fr) |
WO (1) | WO1999066051A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6183962B1 (en) * | 1998-09-09 | 2001-02-06 | Millennium Pharmaceuticals, Inc. | Protein kinase molecules and uses therefor |
US20020151005A1 (en) * | 2000-06-15 | 2002-10-17 | Meyers Rachel A. | 53070, a novel human protein kinase family member and uses thereof |
DE10011530A1 (de) * | 2000-03-13 | 2001-09-27 | Robert Elez | Hochwirksame Antisense-Oligodesoxynucleotide gegen Polio-like Kinasel |
AU2001273350A1 (en) * | 2000-07-11 | 2002-01-21 | Deltagen, Inc. | Transgenic mice containing targeted kinase gene disruptions |
AU2002214576A1 (en) * | 2000-10-13 | 2002-04-22 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Genes related to development of refractory prostate cancer |
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
US20040097441A1 (en) * | 2002-11-16 | 2004-05-20 | Isis Pharmaceuticals Inc. | Modulation of NIMA-related kinase 6 expression |
AU2003253678A1 (en) * | 2002-06-11 | 2003-12-22 | The General Hospital Corporation | Identification of inhibitors of mitosis |
CA2907730A1 (fr) * | 2013-03-21 | 2014-09-25 | Bayer Pharma Aktiengesellschaft | Indazoles substitues par diaminoheteroaryle |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863780A (en) * | 1996-09-12 | 1999-01-26 | Incyte Pharmaceuticals, Inc. | Human Protein Kinases |
US6489137B2 (en) * | 1997-06-11 | 2002-12-03 | Chiron Corporation | Detection of loss of the wild-type huBUB1 gene |
US6593098B1 (en) * | 1997-12-01 | 2003-07-15 | Fox Chase Cancer Center | Genes encoding proteins involved in mitotic checkpoint control and methods of use thereof |
AU3187399A (en) * | 1998-03-16 | 1999-10-11 | Johns Hopkins University School Of Medicine, The | Mutations in mitotic check point genes and methods of diagnosis |
US5928874A (en) * | 1998-03-27 | 1999-07-27 | Incyte Pharmaceuticals, Inc. | Nek1-related protein kinase |
JP2002512798A (ja) * | 1998-04-29 | 2002-05-08 | ジェネシス リサーチ アンド デベロップメント コーポレイション リミテッド | 皮膚細胞から単離したポリヌクレオチドおよびその使用方法 |
AU5333899A (en) * | 1998-08-04 | 2000-02-28 | Immunex Corporation | Murine dna molecules encoding polypeptides having kinase functions |
-
1999
- 1999-06-15 WO PCT/US1999/013533 patent/WO1999066051A2/fr not_active Application Discontinuation
- 1999-06-15 EP EP99930298A patent/EP1088079A2/fr not_active Ceased
- 1999-06-15 JP JP2000554860A patent/JP2002518016A/ja not_active Withdrawn
- 1999-06-15 AU AU46862/99A patent/AU4686299A/en not_active Abandoned
- 1999-06-15 CA CA002331889A patent/CA2331889A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002518016A (ja) | 2002-06-25 |
WO1999066051A3 (fr) | 2000-06-15 |
CA2331889A1 (fr) | 1999-12-23 |
WO1999066051A2 (fr) | 1999-12-23 |
EP1088079A2 (fr) | 2001-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5173400A (en) | Protein kinases | |
AU2434199A (en) | Protein | |
AU9790198A (en) | Compounds and methods | |
AU6058500A (en) | Fusion protein and uses thereof | |
AU9781998A (en) | Huchordin and uses thereof | |
AU5091199A (en) | Prion protein and uses thereof | |
AU5340399A (en) | Proteases and associated proteins | |
AU3549499A (en) | Telomerase-associated proteins | |
AU4261197A (en) | Human protein kinases | |
AU6142899A (en) | Human transferase proteins | |
ZA985999B (en) | Protein kinases and uses thereof | |
AU4686299A (en) | Nek-related and bub1-related protein kinases | |
AU3656497A (en) | Traf2-associated protein kinase and assays | |
AU1914400A (en) | Human hydrolase proteins | |
AU2333099A (en) | Aryloxyanilides and related compounds | |
AU2591299A (en) | Human protein kinase c inhibitor | |
AU1456899A (en) | Human protein kinase and kinase inhibitors | |
AU2136401A (en) | P450rai-2 and related proteins | |
AU2538899A (en) | Protein kinase c | |
AU2980799A (en) | Lectomedin materials and methods | |
AU3411999A (en) | Novel rnase-like protein and its use | |
AU2593199A (en) | Human smn-like protein | |
AU4992099A (en) | Human presenilin-associated protein | |
AU6204400A (en) | Novel kinases and uses thereof | |
AU4438599A (en) | Human arf-related proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |